These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 28585180)

  • 1. Efficacy and Safety of Insulin Degludec for Hyperglycemia Management in Noncritical Hospitalized Patients with Diabetes: An Observational Study.
    Simioni N; Filippi A; Scardapane M; Nicolucci A; Rossi MC; Frison V
    Diabetes Ther; 2017 Aug; 8(4):941-946. PubMed ID: 28585180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Insulin Degludec in Hospitalized Patients With and Without Type 2 Diabetes Requiring Parenteral/Enteral Nutrition: An Observational Study.
    Fatati G; Di Donato A; Grandone I; Menicocci P; Mirri E; Prosperini G; Scardapane M; Rossi MC; Palazzi M
    Adv Ther; 2018 Jun; 35(6):809-816. PubMed ID: 29777522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The GesTIO protocol experience: safety of a standardized order set for subcutaneous insulin regimen in elderly hospitalized patients.
    Franchin A; Maran A; Bruttomesso D; Corradin ML; Rossi F; Zanatta F; Barbato GM; Sicolo N; Manzato E
    Aging Clin Exp Res; 2017 Dec; 29(6):1087-1093. PubMed ID: 28238154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Basal insulin glargine using a basal-bolus regimen in a common clinical practice: observational, non-interventional, multicenter, national project LINDA (Lantus in daily practice - safety and efficacy in basal bolus regimen)].
    Zďarská DJ; Brož J; Křivská B; Rušavý Z; Kvapil M
    Vnitr Lek; 2014 Sep; 60(9):712-9. PubMed ID: 25294758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of an Electronic Glycemic Management System Versus Provider-Managed Subcutaneous Basal Bolus Insulin Therapy in the Hospital Setting.
    Aloi J; Bode BW; Ullal J; Chidester P; McFarland RS; Bedingfield AE; Mabrey M; Booth R; Mumpower A; Wallia A
    J Diabetes Sci Technol; 2017 Jan; 11(1):12-16. PubMed ID: 27555601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of basal-bolus insulin regimens in the inpatient management of non-critically ill patients with type 2 diabetes: A systematic review and meta-analysis.
    Christensen MB; Gotfredsen A; Nørgaard K
    Diabetes Metab Res Rev; 2017 Jul; 33(5):. PubMed ID: 28067472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of insulin degludec U100 and insulin glargine U100 in combination with meal-time bolus insulin in hospitalized patients with type 2 diabetes: an open-label, randomized controlled study.
    Suzuki J; Yamakawa T; Oba M; Nagakura J; Shigematsu E; Tamura H; Takahashi K; Okamoto Y; Sakamoto R; Shinoda M; Takano T; Kadonosono K; Terauchi Y
    Endocr J; 2019 Nov; 66(11):971-982. PubMed ID: 31270291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized clinical trial of the efficacy and safety of insulin glargine vs. NPH insulin as basal insulin for the treatment of glucocorticoid induced hyperglycemia using continuous glucose monitoring in hospitalized patients with type 2 diabetes and respiratory disease.
    Ruiz de Adana MS; Colomo N; Maldonado-Araque C; Fontalba MI; Linares F; García-Torres F; Fernández R; Bautista C; Olveira G; de la Cruz JL; Rojo-Martínez G; Valdés S
    Diabetes Res Clin Pract; 2015 Nov; 110(2):158-65. PubMed ID: 26474657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Basal-Bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes.
    Bellido V; Suarez L; Rodriguez MG; Sanchez C; Dieguez M; Riestra M; Casal F; Delgado E; Menendez E; Umpierrez GE
    Diabetes Care; 2015 Dec; 38(12):2211-6. PubMed ID: 26459273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addressing hyperglycemia from hospital admission to discharge.
    Moghissi ES
    Curr Med Res Opin; 2010 Mar; 26(3):589-98. PubMed ID: 20078323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Switching from Twice-Daily Basal Insulin Injections to Once-Daily Insulin Degludec Injection for Basal-Bolus Insulin Regimen in Japanese Patients with Type 1 Diabetes: A Pilot Study.
    Tosaka Y; Kanazawa A; Ikeda F; Iida M; Sato J; Matsumoto K; Uchida T; Tamura Y; Ogihara T; Mita T; Shimizu T; Goto H; Ohmura C; Fujitani Y; Watada H
    Int J Endocrinol; 2015; 2015():176261. PubMed ID: 26435713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Switching Patients with Type 1 Diabetes to Insulin Degludec from Other Basal Insulins: Real-World Data of Effectiveness and Safety.
    Ponzani P; Berra C; Di Lelio A; Del Sindaco P; Di Loreto C; Reggiani F; Lucisano G; Rossi MC
    Diabetes Ther; 2020 Jan; 11(1):97-105. PubMed ID: 31707573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Switching from twice-daily glargine or detemir to once-daily degludec improves glucose control in type 1 diabetes. An observational study.
    Galasso S; Facchinetti A; Bonora BM; Mariano V; Boscari F; Cipponeri E; Maran A; Avogaro A; Fadini GP; Bruttomesso D
    Nutr Metab Cardiovasc Dis; 2016 Dec; 26(12):1112-1119. PubMed ID: 27618501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of a dose-defining insulin infusion protocol among trauma service intensive care unit admissions.
    Braithwaite SS; Edkins R; Macgregor KL; Sredzienski ES; Houston M; Zarzaur B; Rich PB; Benedetto B; Rutherford EJ
    Diabetes Technol Ther; 2006 Aug; 8(4):476-88. PubMed ID: 16939372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Use Frequency of a Mobile Diabetes Management App on Blood Glucose Control: Evaluation Study.
    Vehi J; Regincós Isern J; Parcerisas A; Calm R; Contreras I
    JMIR Mhealth Uhealth; 2019 Mar; 7(3):e11933. PubMed ID: 30843865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycemic Variability in Type 1 Diabetes Compared with Degludec and Glargine on the Morning Injection: An Open-label Randomized Controlled Trial.
    Iga R; Uchino H; Kanazawa K; Usui S; Miyagi M; Kumashiro N; Yoshino H; Ando Y; Hirose T
    Diabetes Ther; 2017 Aug; 8(4):783-792. PubMed ID: 28547206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of multiple daily injection therapy with Humalog mixtures versus separately injected insulin lispro and NPH insulin in adults with type I diabetes mellitus.
    Roach P; Bai S; Charbonnel B; Consoli A; Taboga C; Tiengo A; Bolli G;
    Clin Ther; 2004 Apr; 26(4):502-10. PubMed ID: 15189747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a Nurse-Managed Insulin Infusion Protocol.
    Passarelli AJ; Gibbs H; Rowden AM; Efird L; Zink E; Mathioudakis N
    Diabetes Technol Ther; 2016 Feb; 18(2):93-9. PubMed ID: 26583890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A unified Hyperglycemia and Diabetic ketoacidosis (DKA) insulin infusion protocol based on an Excel algorithm and implemented via Electronic Medical Record (EMR) in Intensive Care Units.
    Gupta D; Kirn M; Jamkhana ZA; Lee R; Albert SG; Rollins KM
    Diabetes Metab Syndr; 2017; 11(4):265-271. PubMed ID: 27658894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive insulin protocol implementation and outcomes in the medical and surgical wards at a Veterans Affairs Medical Center.
    Chen HJ; Steinke DT; Karounos DG; Lane MT; Matson AW
    Ann Pharmacother; 2010 Feb; 44(2):249-56. PubMed ID: 20103610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.